Cefoxitin
Cefoxitin for Injection, USP
Approved
Approval ID
91ac4c14-8dd8-4efe-a462-d1c488a6184f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 12, 2023
Manufacturers
FDA
WG Critical Care, LLC
DUNS: 829274633
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefoxitin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-245
Application NumberANDA065414
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefoxitin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 12, 2023
FDA Product Classification
INGREDIENTS (2)
CEFOXITIN SODIUMActive
Quantity: 1 g in 1 1
Code: Q68050H03T
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM
Cefoxitin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code44567-246
Application NumberANDA065414
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefoxitin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 12, 2023
FDA Product Classification
INGREDIENTS (2)
CEFOXITIN SODIUMActive
Quantity: 2 g in 1 1
Code: Q68050H03T
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM